Skip to main content

plain-language-summary

Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.

Datos de origen

Repositorio
K-Dense-AI/skill-101-webinar
Última actividad en el origen
7 de julio de 2026 a las 00:19
Idioma detectado de SKILL.md
inglés
Estrellas
8
Forks
5

Opciones de instalación

De forma predeterminada está seleccionado el prompt que primero revisa el origen. Puedes cambiar a un comando directo o descargar una copia local.

Revisa los archivos de origen

Lee SKILL.md y los archivos complementarios que muestra SkillsMP antes de decidir si quieres instalarlo.

Mostrando SKILL.md

SKILL.md
Instrucciones de origen · Vista previa de solo lectura
name
plain-language-summary
description
Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.
# Plain-Language Summary ## When to use Any time the user wants technical, jargon-heavy, or dense material made clear for a general reader — abstracts, documentation, reports, emails, papers. ## Output format (ALWAYS use exactly this) **TL;DR:** one plain sentence anyone could understand. **Why it matters:** 1–2 sentences on the real-world significance. **Key points:** - 3–5 bullets, each jargon-free and self-contained. **Caveats:** what's uncertain, assumed, or out of scope (1–2 bullets). ## Rules - No jargon without a 3-word plain explanation in parentheses. - Prefer everyday words; cut filler. - Keep the whole thing under ~200 words unless the user asks for more. - Never invent facts that aren't in the source text; if something is unclear, say so in Caveats. ## Example Input: "We employed a randomized double-blind placebo-controlled trial (n=240) to assess the efficacy of compound X on LDL-C reduction over 12 weeks." Output: **TL;DR:** A careful study tested whether drug X lowers "bad" cholesterol, and it did. **Why it matters:** Lower bad cholesterol usually means lower heart-disease risk. **Key points:** - 240 people took part over 12 weeks. - Neither patients nor doctors knew who got the real drug (double-blind), which reduces bias. - Some got a fake pill (placebo) for comparison. **Caveats:** - 12 weeks is short — long-term effects aren't shown here.
Ver en GitHub